Busulfan
Showing 651 - 675 of 765
Leukemia, MDS Trial in United Kingdom (biological, drug, genetic, other, procedure)
Completed
- Leukemia
- Myelodysplastic Syndromes
- alemtuzumab
- +18 more
-
Basingstoke, England, United Kingdom
- +95 more
Aug 23, 2013
Myeloma Trial in Lyon (reduced intensity conditioning)
Completed
- Myeloma
- reduced intensity conditioning
-
Lyon, FranceMohamad Sobh
Jan 14, 2014
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Berkeley, San Francisco (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +8 more
-
Berkeley, California
- +1 more
Oct 2, 2012
Leukemia, MDS Trial in Seoul (nonmyeloablative allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell
Completed
- Leukemia
- Myelodysplastic Syndromes
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- peripheral blood stem cell transplantation
-
Seoul, Korea, Republic ofAsan Medical Center - University of Ulsan College of Medicine
Jul 16, 2012
Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a)
Completed
- Childhood Acute Erythroleukemia (M6)
- +15 more
- asparaginase
- +15 more
-
Arcadia, CaliforniaChildren's Oncology Group
Jan 15, 2013
GVHD Trial in Italy (polyclonal antibody, Rituximab, Treosulfan)
Unknown status
- Graft Versus Host Disease
- polyclonal antibody
- +6 more
-
Cagliari, Italy
- +3 more
Mar 12, 2013
Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma Trial in Clermont-Ferrand (Fludarabin (post-allograft immunosuppressive
Unknown status
- Chronic Lymphocytic Leukemia
- Lymphocytic Lymphoma
- Fludarabin (post-allograft immunosuppressive therapy modulation and DLI Mononuclear cells from allogenic blood)
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
May 8, 2013
Leukemia, MDS, Myelodysplastic/Myeloproliferative Diseases Trial in Chicago (drug, procedure, radiation)
Completed
- Leukemia
- +2 more
- busulfan
- +4 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012
Leukemia Trial in Houston (Busulfan, Fludarabine)
Hemoglobinopathies, Sickle Cell Disease, Thalassemia Trial in United States (Busulfex, Fludarabine, Alemtuzumab)
New RIC Regimen of BuFlu in Older and/or Intolerable Patients
Unknown status
- Leukemia
- Myelodysplastic Syndrome
- modified BuFlu conditioning
-
Beijing, ChinaPeking University People's Hospital
Apr 9, 2013
Leukemia, MDS Trial in Detroit (busulfan, cyclophosphamide, cyclosporine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +6 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 6, 2012
Leukemia Trial in Houston (Imatinib Mesylate, Fludarabine (Fludara), Busulfan)
Terminated
- Leukemia
- Imatinib Mesylate
- +7 more
-
Houston, TexasUT MD Anderson Cancer Center
Apr 19, 2012
Osteopetrosis Trial in Tehran (Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen), Stem Cell
Unknown status
- Osteopetrosis
- Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)
- +2 more
-
Tehran, Iran, Islamic Republic ofHematology-Oncology & SCT Research Center
May 31, 2012
Lymphoma Trial in Chicago (busulfan, cyclophosphamide, peripheral blood stem cell transplantation)
Completed
- Lymphoma
- busulfan
- +2 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
Jun 8, 2012
Hematologic Malignancies Trial in Houston (Busulfan, Fludarabine)
Completed
- Hematologic Malignancies
- Busulfan
- Fludarabine
-
Houston, TexasUT MD Anderson Cancer Center
Jan 24, 2012
Leukemia, MDS, Myelodysplastic/Myeloproliferative Diseases Trial in Chicago (biological, drug, procedure)
Completed
- Leukemia
- +2 more
- filgrastim
- +3 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012
Hematologic Malignancies Trial in Atlanta (Busulfan, Cyclophosphamide and Fludarabine)
Completed
- Hematologic Malignancies
- Busulfan, Cyclophosphamide and Fludarabine
-
Atlanta, GeorgiaEmory Universtiy Winship Cancer Institute
Apr 5, 2012
Mucositis, Graft-versus-host Disease Trial in Tampa (Tac+MTX, TAC + MMF)
Completed
- Mucositis
- Graft-versus-host Disease
- Tac+MTX
- TAC + MMF
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Mar 22, 2013
Lymphoma Trial in Chicago (drug, procedure, radiation)
Completed
- Lymphoma
- busulfan
- +6 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012
Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (drug, procedure,
Completed
- Chronic Myeloproliferative Disorders
- +2 more
- busulfan
- +3 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012
Lymphoma Trial in Chicago (biological, drug, procedure)
Completed
- Lymphoma
- aldesleukin
- +14 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
May 31, 2012
Hematological Malignancies Trial in Marseille, Nantes, Pessac (Fludarabine, Busulfan, Thymoglobuline)
Completed
- Hematological Malignancies
- Fludarabine, Busulfan, Thymoglobuline
-
Marseille, France
- +2 more
May 15, 2012
Leukemia, MDS Trial in Worldwide (drug, procedure, radiation)
Completed
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +7 more
-
Brugge, Belgium
- +8 more
Jul 13, 2012